Alan Huang

机构：Tango Therapeutics (United States), Stanford Medicine, Stanford University · ORCID：0000-0002-6587-3000

发表论文 10 篇 · 总被引 218 次 · h-index 4

代表论文

• CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors (2024 · Nature · 被引 171)
• Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases (2016 · Endocrinology · 被引 23)
• Significance of CD8+ T cell infiltration-related biomarkers and the corresponding prediction model for the prognosis of kidney renal clear cell carcinoma (2021 · Aging · 被引 9)
• A novel classification method for NSCLC based on the background interaction network and the edge-perturbation matrix (2022 · Aging · 被引 5)
• The Significance of Tumor Microenvironment Score for Breast Cancer Patients (2022 · BioMed Research International · 被引 4)
• Fatal Pulmonary Embolization after Negative Serial Ultrasounds (2014 · Journal of Emergency Medicine · 被引 2)